Please Wait.....
Report
Global Market for Stem Cells
Market Research Report I 2023-03-14 I 139 Pages I BCC Research
Description
Report Scope:
This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed, with profiles of the leading companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of the products involved.
Report Includes:
- 18 data tables and 14 additional tables
- An up-to-date overview and analysis of the global markets for (biological) stem cells and related products
- Analyses of the global market trends, with historic revenue data for 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for global stem cells market in USD million terms, and corresponding market share analysis by product, application, end user, and region
- Highlights of emerging technology trends, market opportunities and deterrents estimating current and future demand of stem cells related products and their derivatives for drug discovery
- Discussion of market dynamics that impact the growth of the market for biological stem cells, clinical applications, market regulations, industry structure, and penetration of technologies within the biotech industry
- Review of the patents and patent applications on stem cell research, and corresponding research/scientific publications during the analysis period
- Competitive landscape of the key manufacturers and suppliers of the stem cell-related drug market, their product portfolios, financial updates, and major growth strategies within the marketplace
- Company profiles of major players within the industry, including 3-D Matrix Medical Technology, International Stem Cell Corp., ReNeuron Group, and U.S. Stem Cell Inc.
Executive Summary
Summary:
Definitions
Stem cells are the first cells formed when an egg and a sperm join, and the resultant zygote begins to divide. They are the precursors of all the different types of cells that make up the body. They are characterized by self-renewal, which is the capacity to continue dividing to make ever-larger populations of stem cells, as well as the capacity to differentiate into any mature cell type when they receive appropriate chemical instructions.
Several broad categories of stem cells exist, including embryonic stem cells, which are derived from blastocysts; fetal stem cells, which are obtained from aborted fetuses; adult stem cells, which are found in adult tissues; cord blood stem cells, which are isolated from umbilical tissue; cancer stem cells, which give rise to a clonal populations of cells that form tumors or disperse in the body; and animal stem cells, which are derived from non-human sources.
Applications
In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells. Researchers are interested in the potential for using stem cells to treat conditions, including diabetes, cardiovascular disease and neurological disorders, by replacing defective cells and tissues; ideally, stem cells function as the raw material from which new populations of normal differentiated cells and tissues develop.
Stem cells can also be used in pharmaceutical research to improve drug target validation and toxicology screening. This is of intense interest to pharmaceutical companies, as it offers a safer alternative to the use of living organisms, including humans, for some aspects of drug testing. Stem cells are also being studied for their ability to improve both the understanding and treatment of birth disorders.
Research and Commercialization
A sizeable stem cell research product market has emerged to facilitate the research resulting from interest in stem cell applications. Large companies selling stem cell research products include Invitrogen, BD Biosciences, Thermo Fisher Scientific and Millipore. Products offered by these companies include antibodies to stem cell antigens, bead-based stem cell separation systems, stem cell protein purification and analysis tools, tools for DNA- and RNA-based Characterization of stem cells, stem cell culture and media reagents, stem-cell-specific growth factors and cytokines, tools for stem cell gene regulation, a range of stem cell services, tools for in vivo and in vitro stem cell tracking, and stem cell lines.
The major market for stem cells will be their use in the treatment of disease, and there are already numerous companies specializing in developing stem cells directed toward specific disease targets. This market opportunity is still largely at an early, experimental stage. The main exception is the use of stem cells taken from the patient's own bone marrow to treat conditions such as leukemia, which is a failure of normal hematopoiesis (i.e., formation of blood cells). This use of stem cells is well established.
A third market opportunity has arisen in the stem cell field based on the collection and preservation of stem cells from the umbilical cord blood after a baby is born. The cells are kept frozen in "cord blood banks" so they may be used by the donor later in life to treat appropriate diseases. This use of stem cells is not generally endorsed by the medical profession, but it has given rise to a kind of medical tourism.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing the Study
1.3 What's New in This Update?
1.4 Scope of Report
1.5 Market Analyses and Forecasts
1.6 Methodology
1.7 Intended Audience
1.8 Information Sources
1.9 Analyst's Credentials
1.10 BCC Custom Research
1.11 Related BCC Research Reports
Chapter 2 Summary and Highlights
2.1 Definitions
2.2 Applications
2.3 Research and Commercialization
2.4 Funding
2.5 Market
Chapter 3 Overview
3.1 Cells
3.2 Stem Cells
3.2.1 Induced Pluripotent Stem Cells
Chapter 4 Stem Cell Research
4.1 History
4.2 Embryonic Stem Cells
4.2.1 Growth and Identification of Embryonic Stem Cells
4.2.2 Stimulating Embryonic Stem Cells to Differentiate
4.3 Adult Stem Cells
4.3.1 Mesenchymal Stem Cells
4.3.2 Hematopoietic Stem Cells
4.3.3 Neural Stem Cell
4.3.4 Endothelial Progenitor Cell
4.3.5 Epithelial Stem Cell
4.3.6 Very Small Embryonic-Like Cell
4.4 Cord Blood Stem Cells
4.5 Induced Pluripotent Stem Cells
4.5.1 Nuclear Reprogramming
4.6 Cell-Based Therapeutics
4.6.1 Embryonic-Derived Stem Cells
4.6.2 Adult and Progenitor-Derived Stem Cells
4.6.3 Engineered Stem Cells for Transplantation
4.7 Therapeutic Stem Cell Banking
4.8 Stem Cell-Based Biomedical Research
4.9 Stem Cell Research Centers
4.10 Regulation of Stem Cell Research
4.10.1 National Regulatory Measures
4.11 Practicalities of Stem Cell Research and Production
4.11.1 Stem Cell Production
4.11.2 Stem Cell Acquisition
4.11.3 Stem Cell Production Economics
4.11.4 Customized Therapy
4.11.5 Banks
4.11.6 Novel Stem Cell Production Developments
4.11.7 Isolation and Engineering
4.11.8 Adult Stem Cells
4.11.9 Embryonic Stem Cells
4.11.10 Induced Pluripotent Stem Cells
4.11.11 Bioprinting
4.12 Stem Cell Banking
4.13 Impact of COVID-19 on Stem Cell Therapy
4.13.1 Impact of COVID-19 on iPSCs
Chapter 5 Stem Cell Applications
5.1 Regenerative Medicine
5.2 Current Stem Cell Therapy Applications
5.2.1 Cancer
Chapter 6 Stem Cell Patents
6.1 General Background on Patents
6.1.1 Stem Cell Patents
6.2 Policies by Country
6.2.1 United States
6.2.2 Canada
6.2.3 European Patent Convention
6.2.4 United Kingdom
6.2.5 Germany
6.2.6 Japan
6.2.7 China
4.3 Induced Pluripotent Stem Cells
4.4 Recent Patent Activity
4.5 Clinical Trials
Chapter 7 Stem Cell Markets
7.1 Markets for Stem Cells
7.2 Market Dynamics
7.2.1 Market Drivers
7.2.2 Market Opportunities by Therapeutic Class
7.3 Global Market Estimates and Forecasts
7.3.1 North America
7.3.2 Europe
7.3.3 Asia-Pacific
7.3.4 Rest of the World
Chapter 8 Emerging Technologies in the Market
8.1 Stem Cell Market in 2022 and Beyond
8.1.1 Oncology Applications
8.1.2 Dermatology Applications
8.1.3 Genetically Modified Stem Cells
8.1.4 Disease Modeling
8.1.5 Sustainable Meat Sources
8.1.6 Bioprinting
8.1.7 Surgery
8.1.8 COVID-19
8.2 Emerging Technologies in Stem Cell Research
Chapter 9 Company Profiles
3-D MATRIX MEDICAL TECHNOLOGY
ATHERSYS INC.
BEIKE BIOTECHNOLOGY CO. LTD.
BRAINSTORM CELL THERAPEUTICS INC.
CELYAD
CYTORI THERAPEUTICS INC.
EPISTEM LTD.
FUJIFILM CELLULAR DYNAMICS INC. (FCDI)
GAMIDA CELL LTD.
HYBRID ORGAN GMBH
INTERNATIONAL STEM CELL CORP.
ARTERIOCYTE MEDICAL SYSTEMS INC. (ISTO BIOLOGICS)
LISATA THERAPEUTICS.
MESOBLAST LTD.
RENEURON GROUP
STEMEDICA CELL TECHNOLOGIES INC.
STEMINA BIOMARKER DISCOVERY INC.
STEMPEUTICS
U.S. STEM CELL INC.
VERICEL CORP.
VERASTEM INC.
VIACYTE INC.
VITRO BIOPHARMA
WICELL RESEARCH INSTITUTE
Chapter 10 Appendix: Glossary
List of Tables
Summary Table : Global Stem Cell Market, by Region, Through 2027
Table 1 : Funding for Various Research, 2016-2023 (Estimated)
Table 2 : Bioprinting Emerging Platforms
Table 3 : Countries Engaged in the ISCBI Program
Table 4 : Patents Related to Induced Pluripotent Stem-Cells, 2021 and 2022
Table 5 : Stem Cell Patents, by Type, 2021
Table 6 : Select Clinical Trials on Stem Cell Research in 2021
Table 7 : Select Clinical Trials on Stem Cell Research in 2022
Table 8 : Select Clinical Trials on Stem Cells in January 2023
Table 9 : Clinical Trials on Various Heart Conditions, 2021-2022
Table 10 : Clinical Trials on Neurodegenerative Diseases, 2021-2022
Table 11 : Global Stem Cell Market, by Region, Through 2027
Table 12 : North American Stem Cell Market, by Country, Through 2027
Table 13 : U.S. Stem Cell Market, Through 2027
Table 14 : Canadian Stem Cell Market, Through 2027
Table 15 : Mexican Stem Cell Market, Through 2027
Table 16 : Regulatory Scenario of European Country
Table 17 : European Stem Cell Market, by Country, Through 2027
Table 18 : French Stem Cell Market, Through 2027
Table 19 : German Stem Cell Market, Through 2027
Table 20 : Italian Stem Cell Market, Through 2027
Table 21 : Spanish Stem Cell Market, Through 2027
Table 22 : U.K. Stem Cell Market, Through 2027
Table 23 : Asia-Pacific Stem Cell Policies, 2021
Table 24 : Asia-Pacific Stem Cell Market, by Country, Through 2027
Table 25 : List of Approved Human Somatic Cell-Processed Products in Japan
Table 26 : Japanese Stem Cell Market, Through 2027
Table 27 : Chinese Stem Cell Market, Through 2027
Table 28 : List of Approved Stem Cell Therapies and Clinical Trials on Stem Cell Therapies for Diseases in India
Table 29 : Cost of Stem Cell Therapy in India, U.K. and U.S.
Table 30 : Indian Stem Cell Market, Through 2027
Table 31 : Rest of the World Stem Cell Market, Through 2027
List of Figures
Summary Figure : Global Stem Cell Market, by Region, 2020-2027
Figure 1 : Early Development of Embryo
Figure 2 : Funding for Stem Cell Research, 2016-2023 (Estimated)
Figure 3 : Stem Cell Therapy Application in Cancer Treatment
Figure 4 : Distribution of Clinical Trial Phases on Stem Cell Therapy, 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security